Akbari Z, Reisi P, Torkaman-Boutorabi A, Farahmandfar M (2020) Effect of pentoxifylline on apoptotic-related gene expression profile, learning and memory impairment induced by systemic lipopolysaccharide administration in the rat hippocampus. Int J Prev Med 11:151
PubMed PubMed Central Google Scholar
Albersen M, Fandel TM, Zhang H, Banie L, Lin G, De Ridder D, Lin CS, Lue TF (2011) Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. Eur Urol 59:286–296
Article CAS PubMed Google Scholar
Ali AA, Abd El-Fattah AI, Abu-Elfotuh K, Elariny HA (2021) Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer’s disease in rats. Int Immunopharmacol 96:107729
Article CAS PubMed Google Scholar
Alzoubi KH, Khabour OF, Tashtoush NH, Al-Azzam SI, Mhaidat NM (2013) Evaluation of the effect of pentoxifylline on sleep-deprivation induced memory impairment. Hippocampus 23:812–819
Article CAS PubMed Google Scholar
Arowoogun J, Akanni OO, Adefisan AO, Owumi SE, Tijani AS, Adaramoye OA (2021) Rutin ameliorates copper sulfate-induced brain damage via antioxidative and anti-inflammatory activities in rats. J Biochem Mol Toxicol 35:e22623
Article CAS PubMed Google Scholar
Ayton S, Lei P, Bush AI (2013) Metallostasis in Alzheimer’s disease. Free Radical Biol Med 62:76–89
Bacchella C, Gentili S, Bellotti D, Quartieri E, Draghi S, Baratto MC, Remelli M, Valensin D, Monzani E, Nicolis S, Casella L, Tegoni M, Dell’Acqua S (2020) Binding and reactivity of copper to R(1) and R(3) fragments of tau protein. Inorg Chem 59:274–286
Article CAS PubMed Google Scholar
Bagheri S, Squitti R, Haertle T, Siotto M, Saboury AA (2017) Role of copper in the onset of Alzheimer’s disease compared to other metals. Front Aging Neurosci 9:446
Barnham KJ, Bush AI (2014) Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chem Soc Rev 43:6727–6749
Article CAS PubMed Google Scholar
Bate C, Williams A (2015) cAMP-inhibits cytoplasmic phospholipase A(2) and protects neurons against amyloid-beta-induced synapse damage. Biology 4:591–606
Article CAS PubMed PubMed Central Google Scholar
Bath PM, Wardlaw JM (2015) Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke 10:469–478
Article PubMed PubMed Central Google Scholar
Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insights in Alzheimer’s disease. Lancet Neurol 12:92–104
Article CAS PubMed Google Scholar
Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview. Mol Neurobiol 50:534–544
Article CAS PubMed PubMed Central Google Scholar
Campos C, Rocha NB, Vieira RT, Rocha SA, Telles-Correia D, Paes F, Yuan T, Nardi AE, Arias-Carrion O, Machado S, Caixeta L (2016) Treatment of cognitive deficits in Alzheimer’s disease: a psychopharmacological review. Psychiatr Danub 28:2–12
Chen X, Zhang M, Ahmed M, Surapaneni KM, Veeraraghavan VP, Arulselvan P (2021) Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer’s disease in rats. Saudi J Biol Sci 28:4232–4239
Article CAS PubMed PubMed Central Google Scholar
D’Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, Moreno S, Bacci A, Ammassari-Teule M, Marie H, Cecconi F (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s disease. Nat Neurosci 14:69–76
de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT (2010) Caspase activation precedes and leads to tangles. Nature 464:1201–1204
Article PubMed PubMed Central Google Scholar
Elmore SA, Dixon D, Hailey JR, Harada T, Herbert RA, Maronpot RR, Nolte T, Rehg JE, Rittinghausen S, Rosol TJ, Satoh H, Vidal JD, Willard-Mack CL, Creasy DM (2016) Recommendations from the INHAND Apoptosis/Necrosis Working Group. Toxicol Pathol 44:173–188
Article CAS PubMed PubMed Central Google Scholar
Ferreira T, Rasband W (2012) ImageJ User Guide IJ 1.46r. https://imagej.nih.gov/ij/docs/guide/
Fossati S, Giannoni P, Solesio ME, Cocklin SL, Cabrera E, Ghiso J, Rostagno A (2016) The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. Neurobiol Dis 86:29–40
Article CAS PubMed Google Scholar
Gavrilova SI, Alvarez A (2021) Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer’s disease: 30 years of clinical use. Med Res Rev 41:2775–2803
Article CAS PubMed Google Scholar
Giacconi R, Giuli C, Casoli T, Balietti M, Costarelli L, Provinciali M, Basso A, Piacenza F, Postacchini D, Galeazzi R, Fattoretti P, Nisi L, Fabbietti P, Papa R, Malavolta M (2019) Acetylcholinesterase inhibitors in Alzheimer’s disease influence zinc and copper homeostasis. J Trace Elem Med Biol 55:58–63
Article CAS PubMed Google Scholar
Haam J, Yakel JL (2017) Cholinergic modulation of the hippocampal region and memory function. J Neurochem 142(Suppl 2):111–121
Article CAS PubMed PubMed Central Google Scholar
Hayne DJ, Lim S, Donnelly PS (2014) Metal complexes designed to bind to amyloid-beta for the diagnosis and treatment of Alzheimer’s disease. Chem Soc Rev 43:6701–6715
Article CAS PubMed Google Scholar
Herrmann N, Chau SA, Kircanski I, Lanctot KL (2011) Current and emerging drug treatment options for Alzheimer’s disease: a systematic review. Drugs 71:2031–2065
Article CAS PubMed Google Scholar
Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT (2004) Redox-active metals, oxidative stress, and Alzheimer’s disease pathology. Ann N Y Acad Sci 1012:153–163
Article CAS PubMed Google Scholar
Jackson RJ, Rose J, Tulloch J, Henstridge C, Smith C, Spires-Jones TL (2019) Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers. Brain Commun 1:fcz003
Article PubMed PubMed Central Google Scholar
Jiang J, Liu G, Shi S, Li Y, Li Z (2019) Effects of manual acupuncture combined with donepezil in a mouse model of Alzheimer’s disease. Acupunct Med 37:64–71
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jonsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2012) A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature 488:96–99
Article CAS PubMed Google Scholar
Kalovyrna N, Apokotou O, Boulekou S, Paouri E, Boutou A, Georgopoulos S (2020) A 3’UTR modification of the TNF-alpha mouse gene increases peripheral TNF-alpha and modulates the Alzheimer-like phenotype in 5XFAD mice. Sci Rep 10:8670
Article CAS PubMed PubMed Central Google Scholar
Kang JY, Park SK, Guo TJ, Ha JS, Lee DS, Kim JM, Lee U, Kim DO, Heo HJ (2016) Reversal of trimethyltin-induced learning and memory deficits by 3,5-dicaffeoylquinic acid. Oxid Med Cell Longev 2016:6981595
Article PubMed PubMed Central Google Scholar
Khurana R, Uversky VN, Nielsen L, Fink AL (2001) Is Congo red an amyloid-specific dye? J Biol Chem 276:22715–22721
Article CAS PubMed Google Scholar
Kitazawa M, Cheng D, LaFerla FM (2009) Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem 108:1550–1560
Article CAS PubMed PubMed Central Google Scholar
Knorz AL, Quante A (2022) Alzheimer’s disease: efficacy of mono- and combination therapy. A systematic review. J Geriatr Psychiatry Neurol 35:475–486
Kwon KJ, Kim MK, Lee EJ, Kim JN, Choi BR, Kim SY, Cho KS, Han JS, Kim HY, Shin CY, Han SH (2014) Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci 347:66–77
Article CAS PubMed Google Scholar
Liu CY, Bai K, Liu XH, Zhang LM, Yu GR (2018) Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42. Neural Regen Res 13:1974–1980
Comments (0)